SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-22-009309
Filing Date
2022-12-15
Accepted
2022-12-14 20:53:05
Documents
58
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ivbt_10k.htm   iXBRL 10-K 1121213
2 CERTIFICATION ivbt_ex311.htm EX-31.1 10552
3 CERTIFICATION ivbt_ex321.htm EX-32.1 4248
9 ivbt_10kimg10.jpg GRAPHIC 2988
10 ivbt_10kimg8.jpg GRAPHIC 3604
  Complete submission text file 0001477932-22-009309.txt   4229242

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivbt-20220831.xsd EX-101.SCH 46556
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivbt-20220831_lab.xml EX-101.LAB 259661
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ivbt-20220831_cal.xml EX-101.CAL 47082
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivbt-20220831_pre.xml EX-101.PRE 219142
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ivbt-20220831_def.xml EX-101.DEF 128048
52 EXTRACTED XBRL INSTANCE DOCUMENT ivbt_10k_htm.xml XML 455046
Mailing Address 40 WALL STREET, SUITE 2701 NEW YORK NY 10005
Business Address 40 WALL STREET, SUITE 2701 NEW YORK NY 10005 640-380-1923
Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)

IRS No.: 822275255 | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-55852 | Film No.: 221463487
SIC: 2834 Pharmaceutical Preparations